Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations.
about
Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytes.An engineered food-grade Lactococcus lactis strain for production and delivery of heat-labile enterotoxin B subunit to mucosal sitesAdjuvants are Key Factors for the Development of Future Vaccines: Lessons from the Finlay Adjuvant Platform.Recombinant vaccines and the development of new vaccine strategies.Neisseria lactamica antigens complexed with a novel cationic adjuvantChallenges in the research and development of new human vaccines.Adjuvants and delivery systems for antifungal vaccines: current state and future developments.The Hen's Egg Test on Chorioallantoic Membrane: An Alternative Assay for the Assessment of the Irritating Effect of Vaccine Adjuvants.Mucosal and systemic immune responses induced by a single time vaccination strategy in mice.A novel mucosal vaccine targeting Peyer's patch M cells induces protective antigen-specific IgA responses.Post-operative unadjuvanted therapeutic xenovaccination with chicken whole embryo vaccine suppresses distant micrometastases and prolongs survival in a murine Lewis lung carcinoma model.Microcrystalline Cellulose for Delivery of Recombinant Protein-Based Antigen against Erysipelas in Mice.
P2860
Q35013272-873BBF91-6184-495B-B3EB-B6A33C5385F1Q36298813-E7383EF7-800A-4C14-BA6C-90174FB57233Q37353525-DFA9B2D1-B93D-4337-A8AF-004F2E4C2A56Q37370940-048FD46C-B1ED-449E-9C75-32C5547EC168Q37478314-8A1AFD43-8933-468C-A5BF-736D8C4E51E5Q38096300-B828B51A-F957-44C1-BEBA-2ED6BA9CA635Q38264288-D92FEA76-D348-4F69-9A03-C01ECC3CCC37Q39298187-4608C6BB-A62D-4B72-918B-0A66B6289873Q41125196-F169DD74-F292-4BB1-966A-CC721B216C66Q43990531-2BEF3382-9BDD-47CC-97E5-0702DECE0FABQ52649737-8DAF6420-CAA3-4894-A4A0-3F1311E82067Q55501344-69E0AAD3-2EDE-43D0-8452-9639A16C607B
P2860
Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 April 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human prophylactic vaccine adj ...... e in new vaccine formulations.
@en
Human prophylactic vaccine adj ...... e in new vaccine formulations.
@nl
type
label
Human prophylactic vaccine adj ...... e in new vaccine formulations.
@en
Human prophylactic vaccine adj ...... e in new vaccine formulations.
@nl
prefLabel
Human prophylactic vaccine adj ...... e in new vaccine formulations.
@en
Human prophylactic vaccine adj ...... e in new vaccine formulations.
@nl
P2093
P2860
P1476
Human prophylactic vaccine adj ...... le in new vaccine formulations
@en
P2093
E González
V E J C Schijns
P2860
P304
P356
10.1590/S0100-879X2012007500067
P407
P577
2012-04-26T00:00:00Z